H100 Group ABFRA:GS9 33 EBIT per Share is €-0.01 as of Dec. 2025. GuruFocus rates FRA:GS9 with a GF Score™ of 33/100. The stock has 2 warning signs investors should review. Among 529 Healthcare Providers & Services companies, H100 Group AB ranks worse than 189035.73% on this metric.
H100 Group AB's EBIT per Share for the
six
months ended in Dec. 2025 was €0.00.
Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2025 was €-0.01.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for H100 Group AB's EBIT per Share or its related term are showing as below:
During the past 8 years, the highest 3-Year average EBIT per Share Growth Rate of H100 Group AB was 31.50% per year. The lowest was -49.90% per year. And the median was -9.20% per year.
FRA:GS9's 3-Year EBIT Growth Rate is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 12.1 * Ranked among companies with meaningful 3-Year EBIT Growth Rate only.
H100 Group AB's EBIT for the
six
months ended in Dec. 2025 was €0.00 Mil.
H100 Group AB (FRA:GS9) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
H100 Group AB EBIT per Share Related Terms
H100 Group AB EBIT per Share Historical Data
* Premium members only.
The historical data trend for H100 Group AB's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-0.01
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
H100 Group AB (FRA:GS9) has a EBIT per Share of €-0.01 as of Dec. 2025. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on H100 Group AB and its competitors. According to the industry distribution chart, H100 Group AB ranks #999999 out of 529 companies in the Healthcare Providers & Services industry.
Is H100 Group AB's EBIT per Share too high?
H100 Group AB's current EBIT per Share is €-0.01. Based on the distribution chart, H100 Group AB ranks #999999 out of 529 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, H100 Group AB has a GF Score™ of 33/100, reflecting its overall financial health beyond just this single metric.
How does H100 Group AB's EBIT per Share compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, H100 Group AB ranks #999999 out of 529 companies for EBIT per Share. This places H100 Group AB in the lower half of its industry. The industry median EBIT per Share is 12.10. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Healthcare Providers & Services company?
The median EBIT per Share among Healthcare Providers & Services companies is 12.10, based on 529 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on H100 Group AB and its competitors. For the Healthcare Providers & Services industry, the median EBIT per Share is 12.10 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. H100 Group AB's current EBIT per Share is €-0.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is H100 Group AB stock overvalued right now?
H100 Group AB (FRA:GS9) has a current EBIT per Share of €-0.01. The current EBIT per Share is €-0.01. H100 Group AB's overall GF Score™ is 33/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For H100 Group AB (FRA:GS9), the current EBIT per Share is €-0.01 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
H100 Group AB is a Swedish health technology company and the Bitcoin Treasury Company in the Nordics. The Company's objective is to maximize Bitcoin exposure per share by expanding its Bitcoin treasury through financial instruments. The Company operates through two business areas: Bitcoin Treasury operations, which focus on increasing Bitcoin exposure per share through strategic and financial instruments, and a health-tech division that supports health and longevity providers with AI-powered automation and growth tools. The Company generates revenue from digital services related to training and nutrition coaching provided to B2C customers and SaaS revenue related to the Group's digital platform provided to B2B customers. It operates in Sweden and Norway.
33GF Score
Get the complete analysis for FRA:GS9
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:GS9 has been successfully added to your 
